STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNMD
  4. [Form 4] CONMED Corp Insider Trading Activity

Director at CONMED (NYSE: CNMD) exercises 668 RSUs and receives 5,772-unit equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CONMED Corp director David M. Bronson reported compensation-related equity activity. On June 2, 2026, he exercised 668 restricted stock units into the same number of common shares, bringing his direct common stock holdings to 17,909 shares.

On June 1, 2026, he received a new award of 5,772 RSUs under CONMED’s 2025 Long-Term Incentive Plan. Each RSU represents a contingent right to one share of common stock and generally vests 100% after one year. These transactions are reported as grants and derivative exercises rather than open-market buys or sells.

Positive

  • None.

Negative

  • None.
Insider Bronson David M.
Role null
Type Security Shares Price Value
Exercise RSUs (Restricted Stock Units) 668 $0.00 --
Exercise Common Stock 668 $0.00 --
Grant/Award RSUs (Restricted Stock Units) 5,772 $0.00 --
Holdings After Transaction: RSUs (Restricted Stock Units) — 0 shares (Direct, null); Common Stock — 17,909 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
RSUs exercised 668 shares Common stock received from RSU exercise on June 2, 2026
RSU grant size 5,772 RSUs New award on June 1, 2026 under 2025 Long-Term Incentive Plan
Shares owned after transactions 17,909 shares Direct common stock holdings following June 2, 2026 exercise
RSU vesting schedule 100% after one year Applies to RSUs under 2025 Long-Term Incentive Plan
RSU expiration dates 2035 and 2036 Expiration for exercised 668 RSUs and new 5,772 RSU award
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2025 Long-Term Incentive Plan financial
"will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan"
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bronson David M.
(Last)(First)(Middle)
C/O CONMED CORPORATION
11311 CONCEPT BOULEVARD
(Street)
LARGO FLORIDA 33773
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2026M668A$017,909D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
RSUs (Restricted Stock Units)$006/01/2026A5,77206/01/2027(1)06/01/2036Common Stock5,772$05,772D
RSUs (Restricted Stock Units)$006/02/2026M66806/02/2026(2)06/02/2035Common Stock668$00D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
/s/ Thomas Fistek for David M. Bronson by Power of Attorney06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity transactions did CONMED (CNMD) director David M. Bronson report?

David M. Bronson reported exercising 668 restricted stock units into common stock and receiving a new grant of 5,772 RSUs. Both actions are compensation-related, recorded as a derivative exercise and an equity award rather than open-market buying or selling.

How many CONMED (CNMD) shares does David M. Bronson hold after these transactions?

After exercising 668 RSUs into common stock, David M. Bronson directly holds 17,909 shares of CONMED common stock. This figure reflects his reported post-transaction position in the Form 4, excluding any additional holdings not shown in this specific filing.

What are the terms of David M. Bronson’s new 5,772 RSU award at CONMED (CNMD)?

The 5,772 RSUs awarded to David M. Bronson each represent a contingent right to receive one CONMED common share. They are granted under the 2025 Long-Term Incentive Plan and are generally scheduled to vest 100% after a one-year period from the grant date.

Are David M. Bronson’s recent CONMED (CNMD) transactions open-market stock purchases or sales?

The reported transactions are not open-market trades. They include a derivative exercise of 668 restricted stock units into common shares and a grant of 5,772 RSUs, both coded as compensation-related awards and exercises rather than market purchases or sales.

When do David M. Bronson’s reported CONMED (CNMD) RSUs vest and expire?

The new 5,772 RSUs generally vest 100% after one year under the 2025 Long-Term Incentive Plan. An exercised RSU block of 668 units previously had an expiration date in 2035, while the new RSU award carries an expiration date in 2036 according to the filing data.